Takara Bio USA collaborates with Illumina on a single-cell-resolution spatial mapping workflow, presented at AGBT 2026.
At AGBT, customers will present data demonstrating unparalleled scale and sensitivity in research spanning pulmonary fibrosis, prostate cancer, and 3D reconstructions of mouse brains Company expands ...
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 26, 2026 ...
A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...
Researchers launched external beta testing of a 3D spatial transcriptomics system that maps intact tumors in three dimensions and enabling single-cell resolution.
Stellaromics, announced the installation of its first U.S.-based Pyxa™ system at the University of California, Irvine (UCI). This milestone marks a significant expansion of Stellaromics' global beta ...
Applying single-cell RNA sequencing has led researchers to be able to profile the entire transcriptome of cells. However, these transcriptomes prove difficult to link back to their original location ...
"Spatial transcriptomics opens entirely new pathways to gain crucial insight into the cellular function of organisms," said Steve Barnard, PhD, chief technology officer of Illumina. "Illumina spatial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results